ÂÜÀòÂÒÂ×

Yossi Gilgun-Sherki is a pharmaceutical executive who has dedicated their career to developing new drugs and medical devices. Yossi is currently the advisor at NeuroSense Therapeutics, but they have also held senior positions at Teva Pharmaceuticals and Dexcel Pharma.

Gilgun-Sherki has always been interested in the field of neuroscience and they have worked on developing new products for the treatment of neurological disorders for many years. Yossi has led global clinical programs for both MS and CNS products at Teva Pharmaceuticals, and has also served as the head of specialty products R&D at Dexcel Pharma.

Gilgun-Sherki is an expert in the field of drug development and they have extensive experience in working with global regulatory authorities such as the FDA, EMA, and CFDA. Yossi is also a member of R&D management at NeuroSense Therapeutics.

Yossi Gilgun-Sherki was educated at Tel Aviv University, where they obtained their PhD in Neuroprotection strategies in neurodegenerative diseases. Yossi also holds a Master of Business Administration (MBA) from The Open University of Israel in Marketing & Health Innovation.